牛奶过敏的检测和处理:德尔菲共识研究。

Clinical & Experimental Allergy Pub Date : 2022-07-01 Epub Date: 2022-06-10 DOI:10.1111/cea.14179
Hilary I Allen, Ursula Pendower, Miriam Santer, Marion Groetch, Mitchell Cohen, Simon H Murch, Hywel C Williams, Daniel Munblit, Yitzhak Katz, Neeraj Gupta, Sabeen Adil, Justine Baines, Eefje G P M de Bont, Matthew Ridd, Victoria L Sibson, Alison McFadden, Jennifer J Koplin, Josephine Munene, Michael R Perkin, Scott H Sicherer, Robert J Boyle
{"title":"牛奶过敏的检测和处理:德尔菲共识研究。","authors":"Hilary I Allen, Ursula Pendower, Miriam Santer, Marion Groetch, Mitchell Cohen, Simon H Murch, Hywel C Williams, Daniel Munblit, Yitzhak Katz, Neeraj Gupta, Sabeen Adil, Justine Baines, Eefje G P M de Bont, Matthew Ridd, Victoria L Sibson, Alison McFadden, Jennifer J Koplin, Josephine Munene, Michael R Perkin, Scott H Sicherer, Robert J Boyle","doi":"10.1111/cea.14179","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is significant overdiagnosis of milk allergy in young children in some countries, leading to unnecessary use of specialized formula. This guidance, developed by experts without commercial ties to the formula industry, aims to reduce milk allergy overdiagnosis and support carers of children with suspected milk allergy.</p><p><strong>Methods: </strong>Delphi study involving two rounds of anonymous consensus building and an open meeting between January and July 2021. Seventeen experts in general practice, nutrition, midwifery, health visiting, lactation support and relevant areas of paediatrics participated, located in Europe, North America, Middle East, Africa, Australia and Asia. Five authors of previous milk allergy guidelines and seven parents provided feedback.</p><p><strong>Findings: </strong>Participants agreed on 38 essential recommendations through consensus. Recommendations highlighted the importance of reproducibility and specificity for diagnosing milk allergy in children with acute or delayed symptoms temporally related to milk protein ingestion; and distinguished between children directly consuming milk protein and exclusively breastfed infants. Consensus was reached that maternal dietary restriction is not usually necessary to manage milk allergy, and that for exclusively breastfed infants with chronic symptoms, milk allergy diagnosis should only be considered in specific, rare circumstances. Consensus was reached that milk allergy diagnosis does not need to be considered for stool changes, aversive feeding or occasional spots of blood in stool, if there is no temporal relationship with milk protein ingestion. When compared with previous guidelines, these consensus recommendations resulted in more restrictive criteria for detecting milk allergy and a more limited role for maternal dietary exclusions and specialized formula.</p><p><strong>Interpretation: </strong>These new milk allergy recommendations from non-conflicted, multidisciplinary experts advise narrower criteria, more prominent support for breastfeeding and less use of specialized formula, compared with current guidelines.</p>","PeriodicalId":10148,"journal":{"name":"Clinical & Experimental Allergy","volume":"52 1","pages":"848-858"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Detection and management of milk allergy: Delphi consensus study.\",\"authors\":\"Hilary I Allen, Ursula Pendower, Miriam Santer, Marion Groetch, Mitchell Cohen, Simon H Murch, Hywel C Williams, Daniel Munblit, Yitzhak Katz, Neeraj Gupta, Sabeen Adil, Justine Baines, Eefje G P M de Bont, Matthew Ridd, Victoria L Sibson, Alison McFadden, Jennifer J Koplin, Josephine Munene, Michael R Perkin, Scott H Sicherer, Robert J Boyle\",\"doi\":\"10.1111/cea.14179\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>There is significant overdiagnosis of milk allergy in young children in some countries, leading to unnecessary use of specialized formula. This guidance, developed by experts without commercial ties to the formula industry, aims to reduce milk allergy overdiagnosis and support carers of children with suspected milk allergy.</p><p><strong>Methods: </strong>Delphi study involving two rounds of anonymous consensus building and an open meeting between January and July 2021. Seventeen experts in general practice, nutrition, midwifery, health visiting, lactation support and relevant areas of paediatrics participated, located in Europe, North America, Middle East, Africa, Australia and Asia. Five authors of previous milk allergy guidelines and seven parents provided feedback.</p><p><strong>Findings: </strong>Participants agreed on 38 essential recommendations through consensus. Recommendations highlighted the importance of reproducibility and specificity for diagnosing milk allergy in children with acute or delayed symptoms temporally related to milk protein ingestion; and distinguished between children directly consuming milk protein and exclusively breastfed infants. Consensus was reached that maternal dietary restriction is not usually necessary to manage milk allergy, and that for exclusively breastfed infants with chronic symptoms, milk allergy diagnosis should only be considered in specific, rare circumstances. Consensus was reached that milk allergy diagnosis does not need to be considered for stool changes, aversive feeding or occasional spots of blood in stool, if there is no temporal relationship with milk protein ingestion. When compared with previous guidelines, these consensus recommendations resulted in more restrictive criteria for detecting milk allergy and a more limited role for maternal dietary exclusions and specialized formula.</p><p><strong>Interpretation: </strong>These new milk allergy recommendations from non-conflicted, multidisciplinary experts advise narrower criteria, more prominent support for breastfeeding and less use of specialized formula, compared with current guidelines.</p>\",\"PeriodicalId\":10148,\"journal\":{\"name\":\"Clinical & Experimental Allergy\",\"volume\":\"52 1\",\"pages\":\"848-858\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical & Experimental Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/cea.14179\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/6/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Experimental Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/cea.14179","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/6/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:在一些国家,幼儿对牛奶过敏的过度诊断非常严重,导致不必要地使用专门配方奶粉。该指南由与配方奶粉行业没有商业联系的专家制定,旨在减少牛奶过敏的过度诊断,并为疑似牛奶过敏儿童的护理人员提供支持。方法:德尔菲研究,包括两轮匿名共识建立和2021年1月至7月的公开会议。来自欧洲、北美、中东、非洲、澳大利亚和亚洲的17名专家参加了会议,他们分别来自一般医学、营养、助产、保健访问、哺乳支助和儿科相关领域。以前的牛奶过敏指南的5位作者和7位家长提供了反馈。结果:与会者一致通过了38项基本建议。建议强调了诊断与牛奶蛋白摄入有关的急性或延迟症状的儿童牛奶过敏的可重复性和特异性的重要性;并区分了直接食用牛奶蛋白的儿童和纯母乳喂养的婴儿。人们一致认为,通常不需要限制母亲的饮食来控制牛奶过敏,对于有慢性症状的纯母乳喂养的婴儿,牛奶过敏的诊断应该只在特定的、罕见的情况下考虑。人们一致认为,如果与牛奶蛋白摄入没有时间关系,就不需要考虑大便变化、厌恶进食或偶尔出现大便血点。与以前的指导方针相比,这些一致的建议导致了对检测牛奶过敏的更严格的标准,以及对产妇饮食排除和专门配方奶粉的更有限的作用。解释:与目前的指南相比,这些新的牛奶过敏建议来自无冲突的多学科专家,建议更窄的标准,更突出地支持母乳喂养,减少使用专门配方奶粉。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Detection and management of milk allergy: Delphi consensus study.

Background: There is significant overdiagnosis of milk allergy in young children in some countries, leading to unnecessary use of specialized formula. This guidance, developed by experts without commercial ties to the formula industry, aims to reduce milk allergy overdiagnosis and support carers of children with suspected milk allergy.

Methods: Delphi study involving two rounds of anonymous consensus building and an open meeting between January and July 2021. Seventeen experts in general practice, nutrition, midwifery, health visiting, lactation support and relevant areas of paediatrics participated, located in Europe, North America, Middle East, Africa, Australia and Asia. Five authors of previous milk allergy guidelines and seven parents provided feedback.

Findings: Participants agreed on 38 essential recommendations through consensus. Recommendations highlighted the importance of reproducibility and specificity for diagnosing milk allergy in children with acute or delayed symptoms temporally related to milk protein ingestion; and distinguished between children directly consuming milk protein and exclusively breastfed infants. Consensus was reached that maternal dietary restriction is not usually necessary to manage milk allergy, and that for exclusively breastfed infants with chronic symptoms, milk allergy diagnosis should only be considered in specific, rare circumstances. Consensus was reached that milk allergy diagnosis does not need to be considered for stool changes, aversive feeding or occasional spots of blood in stool, if there is no temporal relationship with milk protein ingestion. When compared with previous guidelines, these consensus recommendations resulted in more restrictive criteria for detecting milk allergy and a more limited role for maternal dietary exclusions and specialized formula.

Interpretation: These new milk allergy recommendations from non-conflicted, multidisciplinary experts advise narrower criteria, more prominent support for breastfeeding and less use of specialized formula, compared with current guidelines.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Prize‐winning abstracts from BSACI/WAO 2022 meeting Detection and management of milk allergy: Delphi consensus study. Sublingual immunotherapy with Japanese cedar pollen extract induces apoptosis of memory CD4+ T cells Registry‐based analysis of Icatibant and C1‐inhibitor use in treatment of laryngeal attacks of hereditary angioedema Biomarkers of airway inflammation and immunotherapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1